Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endocrine System Diseases × 6-fluorodopamine × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pheochromocytoma 3 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Endocrine System Diseases 1

Interventions

selpercatinib 2 repotrectinib 1 relacorilant 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 fluorodopa F 18 1 copper dotatate CU-64 1 Sunitinib 1 Lutetium-177 1 Lutetium 1 6-fluorodopamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004847 2026-03-30

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡